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Synaptotagmins (syt) form a large family of transmembrane proteins and some of its isoforms are known to regulate calcium-induced
membrane fusion during vesicular traffic. In view of the reported implication of the isoform syt8 in exocytosis we investigated the expression,
localisation and calcium-sensitivity of syt8 in secretory cells. An immunopurified antipeptide antibody was generated which is directed against a
C-terminal sequence and devoid of crossreactivity towards syt1 to 12. Subcellular fractionation and immunocytochemistry revealed two forms of
synaptotagmin 8 (50 and 40 kDa). Whereas the 40-kDa was present in the cytosol in brain, in PC12 and in clonal β-cells, the 50-kDa form was
localised in very typical clusters and partially colocalised with the SNARE protein Vti1a. Moreover, in primary hippocampal neurons syt8 was
only found within the soma. Amplification of syt8 by RT-PCR indicated that the observed protein variants were not generated by alternative
splicing of the 6th exon and are most likely linked to variations in the N-terminal region. In contrast to the established calcium sensor syt2,
endogenous cytosolic syt8 and transiently expressed syt8-C2AB-eGFP did not translocate upon a raise in cytosolic calcium in living cells. Syt8 is
therefore not a calcium sensor in exocytotic membrane fusion in endocrine cells.
© 2005 Published by Elsevier B.V.Keywords: Calcium-sensor; Subcellular distribution; Exocytosis; Translocation; Pancreatic β-cells; Synaptotagmin1. Introduction
Synaptotagmins form a family of calcium-sensing proteins
implicated in the regulation of membrane fusion in vesicular
transport. They are endowed with a short hydrophilic N-
terminus, followed by a transmembrane domain and two
cytosolic C2-domains. The two isoforms of synaptotagmin
(syt) which have been studied in most detail, syt1 and 2,
bind phospholipids and SNARE proteins in a calcium-
dependant fashion via the C2-domains. Thereby, they attach
to lipid membranes and protein complexes involved in
exocytosis [1,2]. Genetic, electrophysiological and biochem-
ical evidences have established their role as a calcium-sensor
in membrane fusion during exocytosis [1,3]. Several isoforms
have been localised on defined subcellular compartments
suggesting their implication in defined transport steps.⁎ Corresponding author.
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doi:10.1016/j.bbamcr.2005.11.008Whereas syt1, 2, 5 and 9 are found on synaptic vesicles
and/or large dense core vesicles [4–6], syt3 and 6 are present
on plasma membranes or adjacent structures [7,8], syt4
resides in proximity of the trans-Golgi network [8–10] and
syt7 on lysosomes [11].
Synaptotagmins can be classified according to their
biochemical properties or by sequence alignment [12–14].
The latter indicates a close relationship between syt1, 2, 5 and
8 as being paralogues [12–14]. Interestingly, syt1, 2 and 5 are
implicated in the regulation of exocytosis of LDCVs in
neuroendocrine and endocrine cells including insulin-secreting
clonal β-cells [5,6,8,15,16]. In regard to syt8, we have
previously observed that the corresponding mRNA is expressed
in islets as well as derived clonal β-cells and that recombinant
C2-domains of syt8 inhibit insulin exocytosis from permeabi-
lised cells [8]. Recently, a crucial role for syt8 has been reported
in calcium-induced membrane fusion during the acrosome
reaction [17]. However, syt8 lacks several calcium-coordinating
residues in each C2 domain and it remains controversial whether
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proteins in a calcium-dependent fashion [12,17,18].
We have therefore addressed the expression and subcellular
localisation of this isoform and examined membrane binding in
living cells. Our data demonstrate that syt8 exists as a cytosolic
and as a membrane bound form in primary neurons,
neuroendocrine and endocrine cells. The cytosolic form of
syt8 did not translocate to membranes upon increasing calcium
in biochemical assays or in living cells thus excluding this
isoform as a calcium sensor in membrane fusion.2. Material and methods
2.1. Material
Glutathione sepharose 4B was obtained from Amersham Biosciences,
(Saclay, France), collagenase from Roche Diagnostics (Saclay, France) and all
other reagents were from Sigma (Lyon, France). The following commercial
monoclonal antibodies were employed: anti-VAMP2 Cl 69.1 (Synaptic Systems,
Göttingen, Germany); anti-SNAP25 (Sternberger Monoclonals, Lutherville,
MD, USA); anti-Vti1a Cl45, anti-Vti1b Cl7, anti-BiP and anti-PDI (Transduc-
tion Laboratories, Erembodegem, Belgium); anti-calreticulin, anti-membrin and
anti-syntaxin 6 (Stressgen; Victoria, BC, Canada); anti-GST, anti-insulin K36,
anti-syntaxin/HPC-1, anti-βCOP, anti-Golgi 58 K and anti-synaptophysin/
SVP38 (Sigma, Lyon, France). Several antibodies were kindly donated: anti-Ti
VAMP Cl58.2 (Dr. T. Galli, Paris), anti-EEA1 (Dr. J. Grunberg, Genève) and
anti-LAMP1 (Dr. Marie Luisa Malosio, Milano). HRP-linked anti-mouse or
anti-rabbit secondary antibodies were purchased from Amersham Biosciences
(Saclay, France), LysoTracker Red and Alexa-labelled anti-rabbit secondary
antibody were obtained from Molecular Probes (Leiden, Netherlands). A
plasmid encoding PKCα-eGFP was kindly provided by C. Larrson (University
of Lund, Sweden), peGFP-ERGIC by H.P. Hauri (University of Basel,
Switzerland), peGFP-rab7 by B. van Deurs (Panum Institute, Copenhagen),
peGFP-CD63 by G. Griffiths (Cambridge University) and peGFP-SKL by T.
Osumi (University of Hyogo, Japan) [19–22]. INS1-E cells were kindly
provided by C.B. Wollheim and P. Maechler (Université de Genève). The
previously published anti-syt8 antiserum, designated here as AS syt8, was
generously donated by M.A. Knepper (NIH, Bethesda, USA) [23].
2.2. Molecular cloning and RT-PCR
Plasmids encoding the cytoplasmic domains of rat syt 1 to 3 and 5 to 8 fused
to a GST tag were kindly provided by Dr. T. Sudhof [12]. DNA sequence
encoding the cytoplasmic domain of murine syt 4 (residues 63 to 425) was
excised from pSP73 (kind gift from Dr. B. Hilbush) [24] and subcloned into the
SmaI/XhoI sites of pGEX4T-2. cDNA encoding cytoplasmic fragments of other
synaptotagmins were amplified by RT-PCR using the following primer pairs
(restriction sites underlined): syt 9 (from mouse brain, amino acids 48–386) 5′-
AGGATCCTTCTGTCTCTACCGGAAGCG-3′ and 5′-AGAATTCT-
CAGGGTGCAGGTATTGGC-3′, syt 10 (from mouse brain cDNA, amino
acids 92–523) 5′-AGCGGATCCAACCTCAGTGTCCTTCC-3′ and 5′-AGC-
GAATTCTTATGGTGTGGACGGTGGC-3′, syt 11 (from EST AA050913;
amino acids 36–430), 5′-GAAGATCTGTGTGGACGTGCTGCCACC-
AGCAGGC-3′ and 5′-TCGAATTCCGTACTCGCTCAGACTGTGC-
CACTTGGC-3′; Syt 13 (from MIN6 cells cDNA, amino acids 68–426)
5′-ACGGATCCACGGAGCCTGTCCAGC-3′ and 5′-AGCGAATTCTA-
CAGGTGCAGTTGGTGCC-3′. The nomenclature of synaptotagmins is given
according to Fukuda [25]. The PCR products, purified from an agarose gel by
Microspin columns (Qiagen, Courtaboeuf, France), were directly inserted into
the pGEM-T vector (Promega, Charbonnières, France), verified by sequencing
of both strands and then subcloned into the BamHI/EcoRI sites of the pGEX-2T
vector. The plasmid encoding Flag-syt8-C2AB was obtained by subcloning a
EcoRI/HindIII fragment (amino acids 98–360) from pGEX-syt8C2AB into
pCMV-tag. The plasmid coding for syt8C2AB-eGFP was obtained by
amplification of the cytosolic domain of rat syt8 using the following primers5′-TGGTGGAATTCTAGACTCCATGGTTC-3′ and 5′-TAGGATCCGAGC-
GAGGCCTAAGGAG-3′. The amplicon was digested with EcoRI/BamHI,
cloned into the appropriate site of peGFP-N1 and sequenced on both strands.
RNA from indicated sources was purified using Trizol, reverse transcribed and
amplification by PCR was performed using the following primers (according to
sequence NM_018802 [26]): sense (nt 687–705), GCTGTGGGACTT-
CAAGCGG; antisense (nt 1040–1023) ACGGGAACCAAGACG.
2.3. Polyclonal antibody production and immunoblotting
The polyclonal antibody against syt8 was produced by immunisation of New
Zealand white rabbits with a synthetic peptide (CLALQPRLPLLRPR; amino
acids 383 to 394 of Q9R0N6) coupled to KHL (Covalab; Lyon, France). The
resulting antiserum was affinity-purified against the peptide (Syt8) coupled to
sepharose and used throughout the study at a concentration of 35 ng/ml
(immunoblots) or 140 ng/ml (immunofluorescence). This antibody is termed
“anti-syt8 ip”. Recombinant proteins were obtained in E. coli BL21 (DE3),
transformed with pGEX vectors. SDS-PAGE, immunoblots, visualisation and
quantification was performed as published [27]. Attempts to use the antibody in
immunoprecipitation were not successful (data not shown).
2.4. Cell culture and fluorescence microscopy
HIT-T15, MIN6 and INS1-E cells were cultured and transfected as described
[8]. PC12 were generously provided by Dr. Brian Rudkin (ENS, Lyon, France)
and cultured in DMEM supplemented with 7% foetal bovine serum and 7%
horse serum. Primary hippocampal neurons were prepared from rat embryos as
described previously [28]. The following siRNAs were used (Ambion): siRNA1
GGATAAAGAAACTGTGGGCCT corresponding to nts 234–252 and siRNA2
GGGAAGTGGATCGTGTT corresponding to nts 1127–1144 of the rat
sequence AF375467. Note that siRNA1 contains a mismatch in position 11
and was thus used as control. Confocal microscopy was performed as published
and images were obtained using a LSM 510 META and a 100× objective [27].
Fixation of cells either in paraformaldehyde or in methanol at −20 °C gave
similar results for anti-syt8 ip although the latter preserved cytosolic staining to a
larger extent. Permeabilisation with streptolysin-O was performed as described
previously [8] and cells were subsequently incubated for 20 min in intracellular
buffer (140 mM L-glutamic acid/monopotassium salt, 5 mM NaCl, 7 mM
MgSO4, 0.4 mM EGTA, 20 mM HEPES, pH 7) and washed once prior to
fixation. Imaging of living cells was performed using an inverted microscope
(Nikon TD300 equipped with a Z-drive) coupled to a monochromator (Till
Photonics) and appropriate emission filters. Images were recorded by a CCD-
camera (Micromax 1300Y HS, Roperts Scientific) using Metamorph software
(Universal Imaging) and deblurred by deconvolution (Autodeblur, Universal
Imaging). Cells on coverslips were kept either in Krebs–Ringer buffer or in
intracellular buffer at 37 °C on a heated stage during acquisition. Cells were
stimulated either with ionomycin (10 μM) or using defined calcium buffers and
30 μM digitonin. Concentrations of free calcium were obtained as described
previously [29] or, in the case of concentrations above 10 μM, calculated by
winmaxc (http://www.stanford.edu/~cpatton/maxc.html) using NTA and
HEDTA [30]. Solutions were pressure ejected (3 psi, 10 s) from a micropipette
held at approximately 10 μm from the cell.
2.5. Postnuclear supernatants, subcellular fractionation and in vitro
translocation
Cells were washed twice with PBS pH 7.4 (without Mg2+), detached by
incubation with 10 mMEDTA-PBS for 5 min at 37 °C and centrifuged at 800×g
for 5 min at 4 °C. Pelleted cells were resuspended in appropriate buffer for each
experiment and sonicated for 2 min on ice. Brain extracts were prepared as
published [6]. Postnuclear supernatants (PNS) were obtained by a 10-min
centrifugation of cells or brain homogenates at 1000×g and at 4 °C. Subcellular
fractionation by velocity sedimentation on sucrose gradient was performed as
described [31]. To fractionate brain homogenates, PNS was centrifuged at
17,000×g for 1 h yielding P2 (crude synaptosomal fraction) and S2 (soluble
proteins). P2 was resuspended in hypotonic buffer (HEPES 10 mM pH 7.4) and
further lysed by Dounce homogenization. Centrifugation at 27,000×g for 40
Fig. 1. Specificity of immunopurified anti-syt8 antibody. (A) Immunostaining of
recombinant GST-fusion proteins of cytosolic domains of synaptotagmins (GST-
sytC2AB) with anti-GST (upper panel), immunopurified anti-syt8 (antiSyt8 ip;
middle panel) or a different anti-syt8 antiserum (AS Syt8; lower panel).
Numbering of syt isoforms is given according to Fukuda [25]. (B) 60 μg of
postnuclear supernatant from native HIT-T15 cells, HIT-T15 cells over-
expressing Flag-syt8-C2AB (SVIII-C2; left panel), from HIT-T15, MIN6,
INS-1E or PC12 cells (middle panel) or LP1 and S2 fractions from mouse brain
(right panel) were separated by SDS-PAGE by SDS-PAGE and immunoblotted
with anti-syt8 ip (35 ng/ml) in the absence or presence of antigenic peptide
(middle panel). (C) Comparison of immunoreactivity of anti-syt8 ip or AS Syt8
on postnuclear supernatants fromMIN6 and INS1-E cells. Major bands in INS1-
E cells are indicated by arrows. (D) Transient transfection with siRNA2, but not
with (control) siRNA1 reduced the expression of the 40-kDa band in postnuclear
supernatants of INS1-E cells as evidenced by immunoblotting using anti-syt8 ip.
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cell homogenates into membrane and cytosolic fraction, cells were resuspended
in hypotonic buffer (Tris 25 mM pH 7, EDTA 1 mM, EGTA 1 mM, 1 μg/ml
Aprotinin, 1 μg/ml Pepstatin, 1 μg/ml Leupeptin, 0.5 mM PMSF), sonicated and
centrifuged at 100,000×g for 2 h at 4 °C. To determine calcium-dependent
translocation, detached and pelleted MIN6 cells were incubated for 5 min at 37
°C in intracellular buffers supplemented with protease inhibitors (1 μg/ml
Aprotinin, 1 μg/ml Pepstatin, 1 μg/ml Leupeptin, 0.5 mM PMSF)and either
containing 2 mM EGTA or 2 mM CaCl2 with 10 μM ionomycin. Subsequently
they were sonicated on ice for 2 min, centrifuged at 160,000×g for 1 h at 4 °C
and resuspended in EGTA or calcium buffer. Total protein contents were
measured by Bradford assay (Biorad, Marnes-la-Coquette France) and insulin
concentration was determined by ELISA (Mercodia, Uppsala Sweden).
3. Results
3.1. Generation and characterisation of the antibody
Sequence comparison and prediction of antigenicity indicat-
ed a specific and sufficiently antigenic sequence in the C-
terminus of syt8 to avoid cross-reactivity with other isoforms. In
addition, splice variations are not predicted for the last exon in
syt8 [14], the peptide is fully conserved in rat and mouse and
blast searches using the last 30 amino acids of syt8 suggested
the absence of similar sequences in the mouse genome.
Specificity of the obtained and immunopurified antiserum,
termed anti-syt8 ip, was tested against recombinant cytosolic
domains of syt1 to 12 (Fig. 1A). Anti-syt8 ip recognized only
syt8 but no other isoform tested. It should be noted that the
recently identified isoforms syt 13 to 16, which have not been
tested here, do not exhibit any homology to the C-terminus of
syt8. We also used a previously published antiserum [23],
named here AS Syt8, and compared it with anti-syt8 ip. As
given in Fig. 1A, AS Syt8 was specific for synaptotagmin 8 and
exhibited only some cross-reactivity to synaptotagmin 1.
3.2. Expression of synaptotagmin 8
The antibody anti-syt8 ip recognized a single band of 40 kDa
in homogenates from the insulinoma cells HIT-T15 cells (Fig.
1B) and stained an additional band of 35 kDa after over-
expression of the C2AB domains of syt8 in this cell line. The 40-
kDa immunoreactive band was also found in the insulinoma cell
lines MIN6 and INS1-E as well as in pheochromocytoma PC12
cells (Fig. 1B, middle panel) which is in line with the known
extra-neuronal expression of syt8 [12]. As shown in Fig. 1B, the
intensity of the immunoreactive band in endocrine and
neuroendocrine cells was completely abolished by co-incuba-
tion with the antigenic peptide further indicating the specificity
of the antibody employed. In brain homogenates two bands
were detected at 40 and about 50 kDa (Fig. 1B, right panel).
Whereas the upper band was present in LP1 (synaptosomal
plasma membranes and attached synaptic vesicles), the 40-kDa
band was found in the S2 fraction which contains cytoplasm and
synaptic vesicles [32].
We further examined the specificity the immunopurified
antibody by comparing it with AS Syt8 and by the use of siRNA
(Fig. 1C and D). The 40-kDa band is recognized by AS Syt8. In
addition, a band at approximately 50 kDa is stained that can alsobe detected, though faint, in INS1-E cells stained with anti-syt8
ip. Additional bands are apparent using AS syt8 such as a 65-
kDa protein. This may represent synaptotagmin 1 in view of the
cross-reactivity of the antiserum and the known expression of
syt1 in insulin-secreting cell lines [6,8]. Transient transfection
of INS1-E cells with the control siRNA (siRNA1) did not alter
the expression levels of the 40-kDa protein whereas a
Fig. 3. Subcellular distribution of synaptotagmin 8 in clonal β MIN6 cells. (A)
Postnuclear supernatants were fractionated on a continuous sucrose gradient and
14 fractions (0.5 ml each) were analyzed for total protein, insulin, density (upper
graph) and distribution of SNAP25, syntaxin or calreticulin (lower graph). (B)
Immunoblot for synaptophysin (SVP38) and syt8 after short exposure (syt8 ip)
or prolonged exposure (syt8 ip*). (C) Using a similar gradient, the distribution
of immunoreactivity for anti-syt8 ip and for AS syt8 were compared. The
corresponding sucrose concentrations of this gradient are indicated. (D) An
aliquot of the 0.7-M sucrose fraction shown in C was incubated with anti-syt8 ip
in the absence or presence of peptide (10 μM). (E) Postnuclear supernatants of
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of specific siRNA (siRNA2). In contrast, the expression levels
of control proteins such as hsc70 and actin were not altered.
Alternative splicing of syt8 may affect the N- and the C-
terminus with variations at the first two or at the sixth of the
eight exons present thereby yielding proteins with predicted
molecular weights ranging from 25 and 40 to 44 kDa [14]. The
relative migration observed in our experiments is therefore
compatible with the expected forms of syt8. Our attempts to
further characterise syt8 in insulinoma cells by RT-PCR using
sense primers located within the first or second exon were
unsuccessful and may well be explained by the predicted
transcript complexity affecting the N-terminus [14]. Another
splice variant is given by the presence or absence of the 6th
exon situated within the predicted C2B domain [14]. Using
primers situated in the 5th and 7th exon, we obtained amplicons
of the predicted size (353 bp) for the presence of the 6th exon
(Fig. 2) indicating that this exon is expressed in clonal and
primary β-cells.
3.3. Membrane-bound and cytosolic forms of synaptotagmin 8
To determine the subcellular distribution of syt8 in more
detail, we performed fractionation on a continuous sucrose
gradient (Fig. 3) in MIN6 cells. The relative distribution of
known organelle markers coincided with those reported
previously for other insulinoma cells [6,31,33]. Secretory
granules (insulin) migrated mainly at fractions 8 to 10 followed
by the endoplasmic reticulum as given by the distribution of
calreticulin (Fig. 3A). The SNARE proteins syntaxin and
SNAP25 were mainly found in fractions 6 to 8 compatible with
the density of approximately 1 expected for fractions containing
plasma membranes. The broad distribution of the two markers
reflects their known presence also on endocytotic compart-
ments. The vesicular protein synaptophysin/SVP38, a marker of
synaptic-like microvesicles and endocytotic compartments, was
mainly enriched in fraction 5 at a density of approximately 0.9
(Fig. 3B). In contrast, syt8 migrated in the first fractions of the
gradient, a behaviour compatible with a cytosolic protein. After
long exposure of the blots we detected also the 50-kDa band
which was concentrated in fractions of higher density (0.9 M
sucrose). No additional band was observed below or above
these two proteins. To examine the specificity of this band, we
compared the migration of immunoreactive bands on a similarFig. 2. The sixth exon is present in syt8 mRNA from islets and clonal β-cells.
mRNA from indicated sources was amplified using primers situated in the 5th
and 7th exon and separated on agarose gels.
INS1-E cells were separated on a sucrose gradient and two fractions (0.3 M and
0.8 M sucrose) were compared for the expression of the 40- and the 50-kDa
band.gradient using anti-syt8 ip and AS syt8 (Fig. 3C). Both bands
were recognized by the two antibodies and their distribution
over the gradient was comparable in terms of immunoreactivity
for anti-syt8 ip and for AS syt8. An additional band of 48 kDa,
visible between 0.9 and 1.1 M sucrose, was only apparent for
AS syt8.
To ensure the specificity of the 40- and 50-kDa band, we
tested whether the immunoreactivity against both bands can be
blocked by the antigenic peptide. As shown in Fig. 3D, this was
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supernatants of INS1-E cells (see Fig. 1C) although the slower
migrating band was faint (see Fig. 1C). To test for the presence
of the 50-kDa form in INS1-E cells, we also examined fractions
obtained by a sucrose density gradient (Fig. 3E). Similar to our
observations in MIN6 cells, the 50-kDa form was found
enriched at 0.8 M sucrose thus demonstrating its expression also
in this cell line.
3.4. The membrane bound form of synaptotagmin 8 partially
colocalises with Vti1a
To investigate further the distribution of synaptotagmin 8, we
performed immunochemical staining of clonal β-cells (Fig. 4).
Using anti-syt8 ip or AS Syt8, immunoreactivity was dispersed
throughout the cytosol, most likely corresponding to the 40-kDa
protein, and an additional discrete punctuate staining was
observed in MIN6 and INS1-E cells (Fig. 4A–D). A similar
distribution was also apparent in HIT-T15 cells (data not
shown). Although major features in staining were conserved
between anti-syt8ip and AS Syt8, minor differences are notable
such as a greater number of puncta in the latter. This may be due
to cross-reactivity of AS Syt8 with synaptotagmin 1 (see Fig.
1A) known to be expressed on synaptic like microvesicles and
large dense core granules in insulin secreting cells [6]. In
addition, the cytosolic stain was less evident for AS Syt8 which
is in line with the weaker recognition of the 40-kDa protein in
immunoblots.
We further concentrated on the discrete punctua observed
with anti-syt8 ip to ascertain its specificity and define the
relevant structure or organelle. To this end imaging parameters
were employed which mainly visualised the punctuate staining.
The picture shown in Fig. 4E gives a representative image as
obtained by Z-sectioning and 3D reconstruction in INS1-E
cells. Staining of 30 to 50 particles per cell were observed and
these organelles were never found at the plasma membrane. The
magnification provided in Fig. 4E (right panel) demonstrates the
typical aspect of these organelles which most often appeared in
clusters. We further examined the specificity of the staining.
First, it was still apparent after permeabilisation of cells with
streptolysin-O and a buffer wash (Fig. 4F) suggesting that the
epitope recognized by the antibody is tightly associated with
membranes. Preincubation of anti-syt8 ip with the peptide
abolished the immunoreactivity (Fig. 4H) as compared to the
absence of the peptide (Fig. 4G). Moreover, immunoreactivity
was absent in cells cotransfected with siRNA2 (Fig. 4L), but not
in cells co-transfected with siRNA1 (Fig. 4K). The punctate
staining was also considerably altered after preincubation with
nocodazole, which depolymerises tubulin (Fig. 4M). In
contrast, pre-treatment with brefeldin A did not alter the
distribution of anti-syt8ip immunoreactivity (data not shown).
Using a monoclonal antibody against Vti1a, a presumed Golgi
SNARE protein [34], a certain degree of colocalisation was
apparent (Fig. 4N). Comparable results were obtained with AS
syt8 (data not shown). Although a number of syt8-positive
organelles stained for Vti1a, the latter clearly exhibited a wider
distribution. We had therefore conducted a vast survey forcolocalisation with other intracellular structures which, how-
ever, remained negative. Indeed, anti-syt8 ip staining did not
colocalise with markers for peroxisomes (peGFP-SKL), the
endoplasmic reticulum (BiP, calreticulin), the intermediate
compartment (ERGIC-eGFP), transport vesicles (β-COP),
Golgi membranes (membrin, G58k, Vti1b, syntaxin 6),
exocytotic vesicles (insulin, synaptophysin) or endocytic
compartments (Ti-VAMP, LAMP1, rab7-eGFP, EEA1, lyso-
tracker, CD63-eGFP) (data not shown). Similarly, the distribu-
tion of transferrin receptors, cytochrome c oxidase or GLUT2
did not have any resemblance to the localisation of syt8 in
INS1-E cells (data not shown).
Interestingly, a comparable intracellular distribution of anti-
syt8 ip immunoreactivity was apparent in the neuroendocrine
cell line PC12 and in primary neurons. In both cells a limited
number of rather large structures were apparent (Fig. 5). In
neurons, anti-syt8 ip immunoreactivity was strictly confined to
the soma as demonstrated by co-staining for synaptophysin, a
marker of synaptic vesicles, and comparison with the phase
picture.
3.5. Cytosolic synaptotagmin 8 does not translocate in
response to calcium
Synaptotagmin 8 was originally described as an isoform
which does not bind SNARE proteins or phospholipids in a
calcium-dependent manner [12,18]. Most recently, however, it
was reported that the cytosolic domain of syt8 still binds to the
SNARE proteins syntaxin 1 or SNAP25 in a calcium-dependent
manner [13]. We therefore tested whether the cytosolic form of
syt8 expressed in insulinoma cells is capable to bind to
membranes in a calcium-dependent fashion. As shown in Fig. 6,
ultracentrifugation in hypotonic buffer of postnuclear super-
natants from insulinoma cells demonstrated again the soluble
nature of the endogenous protein. We subsequently tested
whether this protein is capable to translocate to biological
membranes upon an increase in free calcium. To this end cells
were incubated in intracellular buffer in the presence of
ionomycin without or with calcium, homogenized and separat-
ed into soluble and membrane fractions by ultracentrifugation.
Under these conditions syt8 remained soluble whereas the
integral membrane proteins VAMP2 and syntaxin were
recovered in the membrane fraction. (Fig. 6). In addition,
transiently expressed protein kinase Cα fully translocated under
those conditions. We further compared the behaviour of the
cytosolic domain of syt8 with that of syt2 in living cells. To this
end eGFP-tagged fusion proteins were expressed in MIN6 cells.
This assay measures interactions with endogenous phospholi-
pids and avoids the problem of contamination of recombinant
proteins by bacterial lipids [35]. As shown in Fig. 6, exposure of
cells to the calcium ionophore ionomycin induced translocation
of syt2C2AB, whereas syt8C2AB remained dispersed through-
out the cell. Stimulation with the calcium mobilizing agent
thapsigargin (1 μM) or carbachol (0.1 mM) did not alter the
distribution of syt8C2AB (data not shown). Using defined
calcium buffers and digitonin to perforate the plasma mem-
brane, we compared the calcium sensitivity of the two
Fig. 4. Immunoreactivity of MIN6 or INS1-E cells using anti-syt8 ip or AS syt8. MIN6 cells are given in panels A and B, all other panels show results using INS-1E
cells. Cells stained with AS syt8 (B and D) exhibit immunofluorescence similar to those stained with anti-syt8 ip (A, C), i.e., a cytosolic and a granular pattern. (E to N)
Staining with anti-syt8 ip and imaging using parameters that image mainly the granular pattern. (E) Pseudo-3D presentation staining with anti-syt8 ip (FITC), syntaxin
1 (TRITC) and Hoechst X (blue) to demonstrate the cellular distribution of anti-syt8 ip staining. Right panel: enlarged view of a group of syt8-positive structures. (F)
Permeabilisation with streptolysin-O and washes prior to fixation and staining with anti-syt8 ip. (G and H) Staining without (G) or with preincubation (H) of anti-syt8
ip with the antigenic peptide (10 μM). (K and L) Staining with anti-syt8 ip of cells co-transfected with eGFP and (control) siRNA1 (K) or siRNA2 (L). (M) Staining
with anti-syt ip (FITC) and anti-tubulin (TRITC) after pre-treatment with nocodazole (5 μg/ml, 1 h, 37 °C). (N) With anti-syt ip (FITC) and anti-Vti1a (TRITC).
Colocalisations of visualised structures are indicated by arrows.
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Fig. 6. Synaptotagmin 8 does not translocate upon increases in intracellular
calcium. (A) Biochemical characterisation: MIN6 cells were incubated in
hypotonic buffer (left panel) or in intracellular buffers in the presence of EGTA
(EGTA) or of 2 mM calcium and 10 mM ionomycin (Calcium) at 37 °C,
sonicated and ultracentrifuged. An aliquot of the initial sample (T) and obtained
supernatants (S) or pellets (P) were immunoblotted for syt8 (using anti-syt8 ip),
syntaxin 1 and VAMP2. (B) MIN6 cells transiently expressing syt2C2AB-eGFP
or syt8C2AB-eGFP kept in KRB (1 mM calcium) were stimulated with 10 μM
ionomycin. Representative frames prior to and 30 s after stimulation are given.
(C) Translocation of syt-eGFP in living cells kept in intracellular buffer and
exposed for 10 s to indicated concentrations of free calcium and 30 μM
digitonin. 3 to 11 cells were imaged for each concentration.
Fig. 5. Immunoreactivity of primary hippocampal neurons or PC12 cells using
anti-syt8 ip. Cells were stained with anti-syt8 ip (FITC) and anti-synaptophysin
(TRITC).
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of free calcium whereas even 1 mM free calcium was unable to
induce translocation of syt8C2AB.
4. Discussion
Characterisation of synaptotagmins has allowed assigning
specific localisation and functional roles to several isoforms of
this family [1]. The expression of multiple splice variants adds
another layer of diversity to the system [14,36,37]. Clearly, the
precise identification and precise localisation of the endogenous
protein is important. We have therefore immunopurified and
carefully characterised our antibody. Its specific recognition of a
soluble 40 kDa and a membrane-bound 50 kDa form of
synaptotagmin 8 is supported by our data using recombinant
synaptotagmin 1 to 12, blockade of recognition by the antigen
in immunoblots and immunofluorescence as well as a decrease
after transfection with corresponding siRNAs. Moreover,similar results were obtained in direct comparison with another,
previously published antibody. Note that we did not detect any
form of higher molecular weight.
Previous studies on endogenous syt8 reported apparent
molecular weights of 40 and 50 kDa in brain or kidney and of
40 and 70 kDa in sperm membranes using anti-peptide
antibodies [23,38]. Recognition of a 40-kDa protein and of
the 50-kDa protein is in line with our study. Transiently
expressed full-length syt8 endowed with an epitope-tag
migrates at approximately 43 kDa [39]. As synaptotagmins
can undergo posttranslational modifications with a corres-
ponding increase in their apparent molecular weight [40,41],
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endogenous synaptotagmin 8.
The detection of a major 40 kDa form was clearly surprising.
Interestingly, the major immunoreactive band in sperm
membranes detected with an antibody directed against a
sequence corresponding to the linker between the two C2
domains exhibited also an apparent molecular weight of 41 kDa
[38]. Our antibody was directed against the C-terminus and we
did not detect any variations by RT-PCR in the 6th exon
encompassing the second C2 domain. Differences between the
two forms should therefore reside within the N-terminal region.
Indeed, a complex pattern of alternative splicing has been
predicted for the N-terminus of syt8 thereby yielding proteins
with predicted molecular weights ranging from 25 and to 44
kDa [14]. This complexity may also explain our failure to
amplify this region by RT-PCR. Note also that spliced N-
terminal EST clones are absent from the different databases. We
cannot formally exclude that the 41-kDa form of syt 8 is
generated by proteolytic cleavage of the 50-kDa protein.
However, the differential distribution observed by immunocy-
tochemistry coincides with the migration on the sucrose
gradient and renders unlikely the occurrence of a proteolytic
artefact during fractionation.
The two forms of syt8 observed in β-cells distributed to
distinct compartments, a soluble 41 kDa form in the cytosol
and a minor 50 kDa membrane-bound. Exon skipping leading
to the absence of transmembrane domains have been reported
previously for several synaptotagmins [36] and a differential
distribution similar to syt8 had been described in the case of
full-length and alternatively spliced syt6 [37]. Despite our
efforts we could only partially characterise the structure
bearing synaptotagmin 8. The effect of microtubule disruption
by nocodazole suggests the expression of synaptotagmin 8 on
a dynamic compartment. Partial colocalisation was apparent
for Vti1a, a vesicular SNARE protein [34]. Although this
protein has been described as residing at the TGN and
derived vesicles, a localisation insensitive to brefeldin A has
been reported recently in adipocytes where Vti1a regulates
trafficking of the glucose transporter GLUT4 [42]. Similarly,
brefeldin A did not alter the subcellular distribution of syt8 in
our cells. We do not think that membrane bound syt8
intervenes in the regulation of glucose transport in β-cells
also it is expressed not only in clonal but also in primary cells
[8]. Indeed, at least the majority of the physiologically
relevant glucose transporter in clonal and primary β-cells,
GLUT2, had a distribution very distinct from that of syt8 in
INS1-E cells (data not shown). Vti1a is, however, found on
aquaporin 2 containing vesicles in renal collecting duct cells
as recently evidenced by a proteomic analysis [43] and
synaptotagmin 8 may eventually intervene in the exocytosis
of channels and transporters in these cells [23] and other
tissues such as β-cells. As other N-terminal splice variants
might exist [14], we cannot exclude that those variants may
eventually localise to exocytotic compartments in cell types
different from those than investigated here.
Both forms of synaptotagmin 8 may intervene in distinct
transport steps and recombinant syt8 C2AB inhibits insulinexocytosis from permeabilised β-cells [8] or sperm acrosome
reaction, a well characterised model of membrane fusion [17].
Obviously such an approach probes for the affinity of the
effector but does not necessarily imply syt8 itself in the
physiological regulation of exocytosis. Indeed, we were unable
to detect any binding to membranes in homogenized or living
cells in the absence or presence of calcium, whereas other C2-
domain containing proteins such as protein kinase Cα or the
cytosolic domain of syt2 completely translocated. This is in line
with the known changes in calcium-coordinating aspartates or
glutamates in syt8. Whereas the first aspartate in the C2A
domain is lacking in syt8, the third aspartate of the C2B domain
is replaced by alanine [12].
Syt8 has been reported to bind in a cation-insensitive manner
to the soluble second messenger inositol 1,3,4,5-tetrakispho-
sphate via a polybasic motif in its C2B domain [44]. A small,
transient increase in this compound has been observed during
stimulation of β-cells by carbachol [45,46]. This agent did not
alter the distribution of syt8 C2AB-eGFP in living cells but we
cannot exclude that minor changes had escaped our attention.
In conclusion, our observations indicate that, similar to
several other synaptotagmins [14,36,37], two forms of syt8
exist in secretory and neuronal cells with a differential
distribution most likely due to alternative splicing. Our
observations also strongly suggest that syt8 is not a calcium
sensor in endocrine cells or neurons and does thus not
participate in the calcium-mediated regulation of evoked
exocytosis.
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